References

1. Tsao CW, et al. Heart disease and stroke statistics-2022 update: A report from the American Heart Association. Circulation. 2022;145(8):e153-e639.
2. Benjamin EJ, et al. Heart disease and stroke statistics—2018 update: A report from the American Heart Association. Circulation. 2018;137(12).
3. Kimblad H, et al. Adult cardiac arrest in the emergency department – A Swedish cohort study. Resuscitation. 2022;175:105-112.
4. Sakai T, et al. Incidence and outcomes of out-of-hospital cardiac arrest with shock-resistant ventricular fibrillation: Data from a large population-based cohort. Resuscitation. 2010;81(8):956-961.
5. Kudenchuk PJ, et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med. 1999;341(12):871-878.
6. Lee YH, et al. Refractory ventricular fibrillation treated with esmolol. Resuscitation. 2016;107:150-155.
7. Benjamin EJ, et al. Heart disease and stroke statistics-2017 update: A report from the American Heart Association. Circulation. 2017;135(10):e146-e603.
8. Hajjar K, et al. Dual defibrillation in patients with refractory ventricular fibrillation. Am J Emerg Med. 2018;36(8):1474-1479.
9. Cheskes S, et al. Double sequential external defibrillation for refractory ventricular fibrillation: The DOSE VF pilot randomized controlled trial. Resuscitation. 2020;150:178-184.
10. Cheskes S, et al. Defibrillation strategies for refractory ventricular fibrillation. N Engl J Med. 2022;387(21):1947-1956.
11. Ramzy M. REBEL Cast Episode 113: Defibrillation Strategies for Refractory Ventricular Fibrillation [podcast]. Available at https://rebelem.com/defibrillation-strategies/. Published December 19, 2022. Accessed June 16, 2023.
12. Wagner D, et al. Comparative effectiveness of amiodarone and lidocaine for the treatment of in-hospital cardiac arrest. Chest. 2023;163(5):1109-1119.
13. Panchal AR, et al. 2018 American Heart Association focused update on advanced cardiovascular life support use of antiarrhythmic drugs during and immediately after cardiac arrest: an update to the American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2018;138(23).
14. de Oliveira FC, et al. Use of beta-blockers for the treatment of cardiac arrest due to ventricular fibrillation/pulseless ventricular tachycardia: a systematic review. Resuscitation. 2012;83(6):674-683.
15. Miraglia D, et al. The evolving role of esmolol in management of pre-hospital refractory ventricular fibrillation; a scoping review. Arch Acad Emerg Med. 2020;8(1):e15.
16. Driver BE, et al. Use of esmolol after failure of standard cardiopulmonary resuscitation to treat patients with refractory ventricular fibrillation. Resuscitation. 2014;85(10):1337-1341.
17. Yannopoulos D, et al. The evolving role of the cardiac catheterization laboratory in the management of patients with out-of-hospital cardiac arrest: a scientific statement from the American Heart Association. Circulation. 2019;139(12):e530-e552.
18. Yannopoulos D, et al. Coronary artery disease in patients with out-of-hospital refractory ventricular fibrillation cardiac arrest. J Am Coll Cardiol. 2017;70(9):1109-1117.
19. Yannopoulos D, et al. Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial. The Lancet. 2020;396(10265):1807-1816.